Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Eiken Chemical CoTSE:4549 +0.73%72 Debt-to-Equity is 0.17 as of Mar. 2026, which is 183% above its 10-year median of 0.06. GuruFocus rates TSE:4549 with a GF Score™ of 72/100 and a GF Value™ of 円2,496.85 (Fairly Valued). The stock has 4 warning signs investors should review. Among 699 Medical Devices & Instruments companies, Eiken Chemical Co ranks better than 63.81% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Eiken Chemical Co's Debt-to-Equity or its related term are showing as below:
TSE:4549'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03 Med: 0.06 Max: 0.17
Current: 0.14
During the past 13 years, the highest Debt-to-Equity Ratio of Eiken Chemical Co was 0.17. The lowest was 0.03. And the median was 0.06.
TSE:4549's Debt-to-Equity is ranked better than 63.81% of 699
companies
in the Medical Devices & Instruments industry
Industry Median: 0.24
vs TSE:4549: 0.14
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Eiken Chemical Co Debt-to-Equity Related Terms
Eiken Chemical Co Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Eiken Chemical Co's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4549 vs ABT, SYK, MDT: Debt-to-Equity Comparison
For the Medical Devices subindustry, Eiken Chemical Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eiken Chemical Co Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eiken Chemical Co's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Eiken Chemical Co's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eiken Chemical Co (TSE:4549) has a Debt-to-Equity of 0.17 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Eiken Chemical Co and its competitors. This is 183% above median its historical median of 0.06. Over the past decade, Eiken Chemical Co's Debt-to-Equity has ranged from 0.03 to 0.17. According to the industry distribution chart, Eiken Chemical Co ranks #253 out of 699 companies in the Medical Devices & Instruments industry, placing it in the top 36.2%.
Is Eiken Chemical Co's Debt-to-Equity too high?
Eiken Chemical Co's current Debt-to-Equity of 0.17 is 183% above median its 10-year median of 0.06. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 0.17. The Medical Devices & Instruments industry median Debt-to-Equity is 0.24. Eiken Chemical Co's value of 0.17 is 29.2% below this industry median. Based on the distribution chart, Eiken Chemical Co ranks #253 out of 699 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Eiken Chemical Co has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eiken Chemical Co's Debt-to-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Eiken Chemical Co ranks #253 out of 699 companies for Debt-to-Equity. This puts Eiken Chemical Co in the upper half of its industry. The industry median Debt-to-Equity is 0.24. Eiken Chemical Co's value of 0.17 is 29.2% below this benchmark. Historically, Eiken Chemical Co's own Debt-to-Equity has ranged from 0.03 to 0.17 over the past decade. While the company's 10-year median is 0.06 vs. the industry median of 0.24, Eiken Chemical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.24, based on 699 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eiken Chemical Co's current Debt-to-Equity of 0.17 is 29.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Eiken Chemical Co and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eiken Chemical Co's current Debt-to-Equity is 0.17, which is 183% above median its own 10-year median of 0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eiken Chemical Co stock overvalued right now?
Based on GuruFocus' analysis, Eiken Chemical Co (TSE:4549) is currently considered Fairly Valued. The stock's GF Value™ is 円2,496.85, compared to a current price of 円2,341.00 — trading 6.2% below its estimated fair value. The current Debt-to-Equity is 0.17, which is 183% above median its 10-year median of 0.06 and 29.2% below the Medical Devices & Instruments industry median of 0.24. Eiken Chemical Co's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Eiken Chemical Co (TSE:4549), the current Debt-to-Equity is 0.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eiken Chemical Co (TSE:4549) Overvalued in 2026?
Based on GuruFocus' analysis, Eiken Chemical Co stock appears to be undervalued.
The current stock price of 円2,341.00 is trading 6.2% below its estimated GF Value™ of 円2,496.85.
GuruFocus considers Eiken Chemical Co to be Fairly Valued.
Key valuation signals for TSE:4549:
Debt-to-Equity: 0.17 (183% above median its 10-year median of 0.06)
GF Value™: 円2,496.85 vs. price of 円2,341.00 (6.2% below fair value)
Industry Position: 29.2% below the Medical Devices & Instruments median (#253 of 699)
No single metric tells the full story. See the TSE:4549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eiken Chemical Co Ltd is a Japan-based company. It manufactures and sells clinical diagnostics and equipment. The company is engaged in processing, manufacture, purchase and sale of test agents, property and casualty insurance agency business. It as a general manufacturer of clinical diagnostics offers a wide range of in vitro diagnostic aids for all fields of medicine. Its major products include the Fecal immunochemical test, Molecular Genetics (LAMP), Microbiology, among many others.
72GF Score
Get the complete analysis for TSE:4549
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4549 has been successfully added to your 
